{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-074014","form_type":"8-K","ticker":"BCYC","cik":"0001761612","company_name":"BICYCLE THERAPEUTICS PLC","filed_at":"2023-06-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.438168+00:00","generated_at":"2026-06-13T18:14:27.671078+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Bicycle Therapeutics appoints Alethia Young as CFO, replaces Lee Kalowski","bullets":["Alethia Young appointed CFO effective ~July 17, 2023; Lee Kalowski resigned effective June 22, 2023.","Young previously CFO of Graphite Bio (GRPH) and biotech analyst at Cantor, Credit Suisse, Deutsche Bank.","Young receives base salary $480,000, bonus target 50%, signing bonus $100,000, option for 120,000 shares.","Travis Thompson appointed Chief Accounting Officer effective June 22, 2023; joined company in 2018.","No family relationships or related-party transactions between new officers and company."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-074014","json":"https://secwatch.observer/filing/0001104659-23-074014.json","markdown":"https://secwatch.observer/filing/0001104659-23-074014.md","text":"https://secwatch.observer/filing/0001104659-23-074014.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1761612/000110465923074014/0001104659-23-074014-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1761612/000110465923074014/tm2319507d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T18:14:27.671078+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3afe9aeb3f","claim":"Travis Thompson was appointed as Chief Accounting Officer at BICYCLE THERAPEUTICS PLC.","evidence_excerpt":"the Board appointed Travis Thompson as the Company’s Chief Accounting Officer and principal accounting officer, effective as of the Transition Date","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465923074014/0001104659-23-074014-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Accounting Officer"}],"fact_type":"executive_change"},{"claim_id":"5cc4119c51","claim":"Alethia Young was appointed as Chief Financial Officer at BICYCLE THERAPEUTICS PLC.","evidence_excerpt":"the Board of Directors (the “ Board ”) of Bicycle Therapeutics plc (the “ Company ”) appointed Alethia Young as Chief Financial Officer and principal financial officer, effective on or about July 17, 2023","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465923074014/0001104659-23-074014-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}